XML 57 R44.htm IDEA: XBRL DOCUMENT v3.6.0.2
Summary Of Significant Accounting Policies (Narrative) (Details) - USD ($)
12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Sep. 29, 2016
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Restricted cash $ 0 $ 0  
Research and development receivables $ 0 $ 0  
Exercise price of warrants     $ 0.70
Reserved shares of common stock 88,525,291 3,083,105  
Revenues $ 32,164,116 $ 37,674,524  
Deferred financing costs   $ 349,018  
Convertible Preferred Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Reserved shares of common stock 37,335,618    
Minimum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Property and equipment, estimated useful lives 3 years    
Intangible assets, estimated useful lives 10 years    
Maximum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Property and equipment, estimated useful lives 10 years    
Intangible assets, estimated useful lives 15 years    
Deferred Service And License Fees [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Deferred revenue, amortization period 1 year    
Stock Options And Stock Appreciation Rights [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Options and stock appreciation rights outstanding 671,887 706,494  
Weighted average exercise price $ 8.77 $ 9.34  
Stock Options And Stock Appreciation Rights [Member] | Minimum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based compensation, requisite service period 1 year    
Stock Options And Stock Appreciation Rights [Member] | Maximum [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Share-based compensation, requisite service period 4 years    
Warrants [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Common stock issuable upon exercise of outstanding warrants 38,963,443    
Exercise price of warrants $ 0.84    
Reserved shares of common stock 38,963,443 2,120,365  
Restricted Stock Units [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unvested restricted shares 1,167,099 752,008  
Restricted Stock [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Unvested restricted shares 0    
Biosense Webster Inc [Member] | Net Revenue [Member] | Customer Concentration Risk [Member]      
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]      
Revenues $ 4,099,075 $ 3,514,897  
Revenues percentage 13.00% 9.00%